Table 6.
Very low density lipoprotein (VLDL) contents in blood samples (μmol/L).
| Group | 0D | 18D | 42D |
|---|---|---|---|
| A | 81.59 ± 12.18 | 106.9 ± 23.96 | 125.0 ± 13.12 |
| B | 95.15 ± 13.84 | 92.50 ± 11.50 | 89.00 ± 13.00** |
| C | 97.48 ± 3.568* | 81.80 ± 12.34 | 79.47 ± 23.60* |
| D | 88.05 ± 13.22 | 74.28 ± 14.69 | 97.69 ± 13.09* |
| F | 120.9 ± 4.996∗∗∗, #,††† | 98.86 ± 14.69 | 72.58 ± 5.376*** |
| G | 121.3 ± 13.33∗∗,† | 93.03 ± 12.43 | 96.84 ± 20.52 |
| I | 91.12 ± 30.99 | 76.08 ± 6.439* | 104.9 ± 20.62 |
Very low density lipoprotein (VLDL) contents were assayed by assay kits as described in the text.
Values were mean ± SD (n = 12) and expressed in μmol/L.
The * indicates a significant difference compared with control group, *P < 0.05, **P < 0.01, ***P < 0.001.
The # indicates a significant difference compared with model group, # P < 0.05.
The † indicates a significant difference compared with PMR group (same dosage level, F compared with C, G compared to D), † P < 0.05, ††† P < 0.001.